These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 34341416)

  • 1. Prognostic significance of the albumin-to-globulin ratio for advanced urothelial carcinoma treated with pembrolizumab: a multicenter retrospective study.
    Taguchi S; Kawai T; Nakagawa T; Nakamura Y; Kamei J; Obinata D; Yamaguchi K; Kaneko T; Kakutani S; Tokunaga M; Uemura Y; Sato Y; Fujimura T; Fukuhara H; Enomoto Y; Nishimatsu H; Takahashi S; Kume H
    Sci Rep; 2021 Aug; 11(1):15623. PubMed ID: 34341416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of the albumin-to-globulin ratio for upper tract urothelial carcinoma.
    Omura S; Taguchi S; Miyagawa S; Matsumoto R; Samejima M; Ninomiya N; Masuda K; Nakamura Y; Yamaguchi T; Kinjo M; Tambo M; Okegawa T; Higashihara E; Fukuhara H
    BMC Urol; 2020 Aug; 20(1):133. PubMed ID: 32859201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Significance of Preoperative Albumin-Globulin Ratio in Patients with Upper Tract Urothelial Carcinoma.
    Zhang B; Yu W; Zhou LQ; He ZS; Shen C; He Q; Li J; Liu LB; Wang C; Chen XY; Fan Y; Hu S; Zhang L; Han WK; Jin J
    PLoS One; 2015; 10(12):e0144961. PubMed ID: 26681341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gustave Roussy Immune score as a prognostic biomarker in patients with platinum-refractory metastatic urothelial carcinoma treated with pembrolizumab: YUSHIMA study.
    Tanabe K; Kobayashi S; Maezawa Y; Ishihara K; Inoue N; Izumi K; Fujiwara M; Toide M; Yamamoto T; Uehara S; Araki S; Inoue M; Takazawa R; Numao N; Ohtsuka Y; Tanaka H; Yoshida S; Fujii Y
    Int J Clin Oncol; 2024 Sep; 29(9):1302-1310. PubMed ID: 38833113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic outcomes and safety in patients treated with pembrolizumab for advanced urothelial carcinoma: experience in real-world clinical practice.
    Tamura D; Jinnouchi N; Abe M; Ikarashi D; Matsuura T; Kato R; Maekawa S; Kato Y; Kanehira M; Takata R; Obara W
    Int J Clin Oncol; 2020 May; 25(5):899-905. PubMed ID: 31907720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic role of preoperative serum albumin/globulin ratio in patients with bladder urothelial carcinoma undergoing radical cystectomy.
    Liu J; Dai Y; Zhou F; Long Z; Li Y; Liu B; Xie D; Tang J; Tan J; Yao K; Zhang Y; Tang Y; He L
    Urol Oncol; 2016 Nov; 34(11):484.e1-484.e8. PubMed ID: 27341738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Albumin-globulin ratio is a predictive biomarker of antitumor effect of anti-PD-1 antibody in patients with non-small cell lung cancer.
    Nakanishi Y; Masuda T; Yamaguchi K; Sakamoto S; Horimasu Y; Mimae T; Nakashima T; Miyamoto S; Tsutani Y; Iwamoto H; Fujitaka K; Miyata Y; Hamada H; Okada M; Hattori N
    Int J Clin Oncol; 2020 Jan; 25(1):74-81. PubMed ID: 31531785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Impact of Preoperative Albumin-Globulin Ratio on Oncologic Outcomes in Upper Tract Urothelial Carcinoma Treated With Radical Nephroureterectomy.
    Xu H; Tan P; Ai J; Huang Y; Lin T; Yang L; Wei Q
    Clin Genitourin Cancer; 2018 Oct; 16(5):e1059-e1068. PubMed ID: 29980449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Value of Albumin/Globulin Ratio in Patients with Upper Tract Urothelial Carcinoma Patients Treated with Radical Nephroureterectomy.
    Fukushima H; Kobayashi M; Kawano K; Morimoto S
    Anticancer Res; 2018 Apr; 38(4):2329-2334. PubMed ID: 29599356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk stratification for the prognosis of patients with chemoresistant urothelial cancer treated with pembrolizumab.
    Kobayashi T; Ito K; Kojima T; Kato M; Kanda S; Hatakeyama S; Matsui Y; Matsushita Y; Naito S; Shiga M; Miyake M; Muro Y; Nakanishi S; Kato Y; Shibuya T; Hayashi T; Yasumoto H; Yoshida T; Uemura M; Taoka R; Kamiyama M; Ogawa O; Kitamura H; Nishiyama H;
    Cancer Sci; 2021 Feb; 112(2):760-773. PubMed ID: 33283385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic value of preoperative serum albumin-globulin ratio for high-grade bladder urothelial carcinoma treated with radical cystectomy: A propensity score-matched analysis.
    Liu Z; Huang H; Li S; Yu W; Li W; Jin J; Li X; Xing J
    J Cancer Res Ther; 2017; 13(5):837-843. PubMed ID: 29237914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decrease of Preoperative Serum Albumin-to-Globulin Ratio as a Prognostic Indicator after Radical Cystectomy in Patients with Urothelial Bladder Cancer.
    Oh JS; Park DJ; Byeon KH; Ha YS; Kim TH; Yoo ES; Kwon TG; Kim HT
    Urol J; 2021 Jan; 18(1):66-73. PubMed ID: 33515214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative albumin/globulin ratio is a potential prognosis predicting biomarker in patients with resectable gastric cancer.
    Xue F; Lin F; Yin M; Feng N; Zhang X; Cui YG; Yi YP; Kong XY; Chen X; Liu WZ
    Turk J Gastroenterol; 2017 Nov; 28(6):439-445. PubMed ID: 29086711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-reactive Protein Is a Prognostic Factor for Survival in Metastatic Upper Tract Urothelial Carcinoma Patients Receiving Pembrolizumab.
    Nagasaka H; Yamamoto S; Suzuki A; Usui K; Terao H; Nakaigawa N; Kishida T
    In Vivo; 2024; 38(4):1823-1828. PubMed ID: 38936923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic role of the preoperative serum albumin : globulin ratio after radical nephroureterectomy for upper tract urothelial carcinoma.
    Otsuka M; Kamasako T; Uemura T; Takeshita N; Shinozaki T; Kobayashi M; Komaru A; Fukasawa S
    Int J Urol; 2018 Oct; 25(10):871-878. PubMed ID: 30103271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic value of the pretreatment serum albumin to globulin ratio for predicting adverse pathology in patients undergoing radical prostatectomy for prostate cancer.
    Chung JW; Ha YS; Kim SW; Park SC; Kang TW; Jeong YB; Park SW; Park J; Yoo ES; Kwon TG; Seo SP; Kang HW; Kim WT; Kim YJ; Lee SC; Kim WJ; Yun SJ; Kim TH
    Investig Clin Urol; 2021 Sep; 62(5):545-552. PubMed ID: 34387034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pembrolizumab for treating advanced urothelial carcinoma in patients with impaired performance status: Analysis of a Japanese nationwide cohort.
    Ito K; Kobayashi T; Kojima T; Hikami K; Yamada T; Ogawa K; Nakamura K; Sassa N; Yokomizo A; Abe T; Tsuchihashi K; Tatarano S; Inokuchi J; Tomida R; Fujiwara M; Takahashi A; Matsumoto K; Shimizu K; Araki H; Kurahashi R; Osaki Y; Tashiro Y; Uegaki M; Ogawa O; Kitamura H; Nishiyama H
    Cancer Med; 2021 May; 10(10):3188-3196. PubMed ID: 33931987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pembrolizumab in Patients with Advanced Urothelial Carcinoma with ECOG Performance Status 2: A Real-World Study from the ARON-2 Project.
    Rizzo A; Monteiro FSM; Ürün Y; Massari F; Park SH; Bourlon MT; Poprach A; Rizzo M; Takeshita H; Giannatempo P; Soares A; Roviello G; Molina-Cerrillo J; Carrozza F; Abahssain H; Messina C; Kopp RM; Pichler R; Formisano L; Tural D; Atzori F; Calabrò F; Kanesvaran R; Buti S; Santoni M
    Target Oncol; 2024 Sep; 19(5):747-755. PubMed ID: 39107651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of albumin to globulin ratio in non-muscle-invasive bladder cancer.
    Quhal F; Pradere B; Laukhtina E; Sari Motlagh R; Mostafaei H; Mori K; Schuettfort VM; Karakiewicz PI; Rouprêt M; Enikeev D; Rink M; Abufaraj M; Shariat SF
    World J Urol; 2021 Sep; 39(9):3345-3352. PubMed ID: 33496841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pembrolizumab in the treatment of advanced urothelial cancer.
    Lundgren KT; Farina MS; Bellmunt J
    Future Oncol; 2017 Dec; 13(30):2745-2758. PubMed ID: 29219016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.